Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Pircher

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Case Reports in Oncology|May 12, 2021
Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported OutcomeMagdalena Pircher, Thomas Winder, Andreas Trojan
Progress in Tumor Research|September 19, 2015
T Cell EngineeringMagdalena Pircher, Thomas Schirrmann, Ulf Petrausch
Clinical Nuclear Medicine|April 29, 2016
Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic PatientsSara Bacanovic, Ruth Stiller, Magdalena Pircher, et al.
Medicine|February 3, 2021
Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case reportMagdalena Pircher, Hans Rudolf Briner, Marco Bonomo, et al.
Anticancer Research|January 10, 2014
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysisSimon Peter Gampenrieder, Franz Romeder, Claudia Muß, et al.
Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.
Anticancer Research|January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trialMagdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized MicePratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Breast Care (Basel, Switzerland)|June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Case Reports in Oncology|May 12, 2021
Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported OutcomeMagdalena Pircher, Thomas Winder, Andreas Trojan
Progress in Tumor Research|September 19, 2015
T Cell EngineeringMagdalena Pircher, Thomas Schirrmann, Ulf Petrausch
Clinical Nuclear Medicine|April 29, 2016
Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic PatientsSara Bacanovic, Ruth Stiller, Magdalena Pircher, et al.
Medicine|February 3, 2021
Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case reportMagdalena Pircher, Hans Rudolf Briner, Marco Bonomo, et al.
Anticancer Research|January 10, 2014
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysisSimon Peter Gampenrieder, Franz Romeder, Claudia Muß, et al.
Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.
Anticancer Research|January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trialMagdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized MicePratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Breast Care (Basel, Switzerland)|June 16, 2022
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Simon P Gampenrieder, Magdalena Pircher, Christian Fesl, et al.
Pageof 1